Trump to announce pharma tariffs soon

U.S. President Donald Trump said on Friday that he would soon announce tariffs targeting the pharmaceutical industry but did not provide details on timing or rates.

Speaking to reporters aboard Air Force One, Trump also stated that he was open to negotiating deals with countries seeking to avoid U.S. tariffs, but such agreements would have to come after his administration announces reciprocal tariffs on April 2.

Countries including Britain have approached the U.S. to discuss potential deals, Trump said.

“They want to make deals. It’s possible if we can get something for the deal,” he noted. However, when asked if these deals could happen before April 2, he ruled it out, saying, “No, probably later. It’s a process.”

Earlier, President Trump announced a 25% tariff on auto imports, claiming it would boost domestic manufacturing. The White House expects the move to generate $100 billion annually, but it could strain automakers reliant on global supply chains.

The tariffs, set to take effect in April, may raise costs and lower sales, though Trump insists they will lead to more U.S. factories.

Declaring the decision “permanent,” he also warned the EU and Canada of even higher tariffs if they coordinate against the U.S.

Related Posts

Unapproved drops for dry eyes pose risks: Govt

NEW DELHI: Flagging that certain yet-to-be-approved dry eye relief drops are being sold in the market, the central drugs regulator has asked states to cancel any permissions granted for these…

Semaglutide Patent Expires: Will Diabetes, Weight-Loss Treatment Become More Accessible For Patients?

The global conversation around obesity and type 2 diabetes management has shifted dramatically in recent years, largely due to the rise of GLP-1 receptor compounds. Among them, semaglutide has emerged…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Unapproved drops for dry eyes pose risks: Govt

Unapproved drops for dry eyes pose risks: Govt

Semaglutide Patent Expires: Will Diabetes, Weight-Loss Treatment Become More Accessible For Patients?

Semaglutide Patent Expires: Will Diabetes, Weight-Loss Treatment Become More Accessible For Patients?

Inaugural Conference of ‘Critical Nephrology Society of India’ (CNSI) puts Best Foot Forward

Inaugural Conference of ‘Critical Nephrology Society of India’ (CNSI) puts Best Foot Forward

Govt highlights multi-layer framework to curb misleading advertisements

Govt highlights multi-layer framework to curb misleading advertisements

Major breakhthrough: Sonbhadra cops nab codeine syrup racket handler in Bengal

Major breakhthrough: Sonbhadra cops nab codeine syrup racket handler in Bengal

Study finds rising resistance to a last-resort antibiotic in Africa

Study finds rising resistance to a last-resort antibiotic in Africa